C1orf106 is a colitis risk gene that regulates stability of epithelial adherens junctions.

Polymorphisms in C1orf106 are associated with increased risk of inflammatory bowel disease (IBD). However, the function of C1orf106 and the consequences of disease-associated polymorphisms are unknown. Here we demonstrate that C1orf106 regulates adherens junction stability by regulating the degradation of cytohesin-1, a guanine nucleotide exchange factor that controls activation of ...
ARF6. By limiting cytohesin-1-dependent ARF6 activation, C1orf106 stabilizes adherens junctions. Consistent with this model, C1orf106-/- mice exhibit defects in the intestinal epithelial cell barrier, a phenotype observed in IBD patients that confers increased susceptibility to intestinal pathogens. Furthermore, the IBD risk variant increases C1orf106 ubiquitination and turnover with consequent functional impairments. These findings delineate a mechanism by which a genetic polymorphism fine-tunes intestinal epithelial barrier integrity and elucidate a fundamental mechanism of cellular junctional control.
Mesh Terms:
ADP-Ribosylation Factors, Adherens Junctions, Animals, Caco-2 Cells, Guanine Nucleotide Exchange Factors, HEK293 Cells, Humans, Immunoprecipitation, Inflammatory Bowel Diseases, Intestinal Mucosa, Mice, Mice, Mutant Strains, Phosphoproteins, Polymorphism, Genetic, Proteolysis, Risk, Ubiquitination
Science
Date: Dec. 09, 2017
Download Curated Data For This Publication
215999
Switch View:
  • Interactions 30